Stocks · Health care · Pharmaceutical Preparations

Avalo Therapeutics, Inc.

AVTX Clue Score19

United States Fiscal year ends December CIK 0001534120 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Mostly scheduled

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$8.50M

$565.64K on a plan · $7.88M straight out of an exercise

Sold at will

$52.01K

1 of 43 sales

Net

−$8.50M

−$52.01K against sales at will